Nigerians to gain access to groundbreaking HIV prevention drug in March

The National Agency for the Control of AIDS (NACA) says Nigerians will gain access to  Lenacapavir, a new drug for HIV prevention, with effect from March 2026.

In a statement on Monday, NACA said it is advancing preparations for the introduction and rollout of the drug as part of federal government commitment to accelerate HIV control in the country.

Lenacapavir is a long-acting HIV prevention drug. It is an injectable PrEP option taken only twice a year.

In clinical trials, Lenacapavir was found to significantly reduce the risk of infection and provide almost total protection against HIV.

“The Government of Nigeria (GON) is advancing preparations for the introduction and rollout of Lenacapavir (LEN) as Pre-Exposure Prophylaxis (PrEP). This is part of Government’s commitment to strengthen HIV prevention and accelerate progress toward epidemic control,” the statement reads.

“Commodities are expected in country in March 2026.”